Department of Homeland Security (DHS) Secretary Kirstjen M. Nielsen released the details of the Fiscal Year (FY) 2020 Budget request to Congress for DHS and its component agencies and offices. The DHS request includes $51.7 billion in discretionary funding and an additional $19.4 billion for the Disaster Relief Fund. The Budget request provides critical resources to help frontline personnel do their jobs to secure the homeland against all threats and hazards, and it ensures DHS is able to defend Americans against emerging dangers.
The U.S. Department of Health and Human Services (HHS) is working with its partners to prepare healthcare systems and enhance response capabilities so we are ready to protect American communities. To prepare the nation to face rapidly evolving and complex health threats, the HHS Office of the Assistant Secretary for Preparedness and Response is enhancing regional preparedness, developing response plans, conducting exercises to ensure those plans can be implemented effectively, and training medical responders from the National Disaster Medical System.
As a critical part of the global response, the U.S. Department of Health and Human Services (HHS) is developing and deploying medical countermeasures, which may help save lives by protecting individuals in the Democratic Republic of the Congo from infection and may reduce the severity of disease. Within HHS, the Office of the Assistant Secretary for Preparedness and Response plays a critical role in medical countermeasure development and use.
The Department of Homeland Security Science and Technology Directorate (S&T), in conjunction with NASA’s Jet Propulsion Laboratory, is researching approaches to bring the possibilities of Internet of Things to emergency communications for first responders. S&T is testing the Wearable Alert and Monitoring System, a multicomponent communications system.
To increase national health security against biothreats and protect public health, the U.S. Department of Health and Human Services (HHS) will partner with Public Health Vaccines LLC of Cambridge, Massachusetts, to develop a potential vaccine against Marburg virus. No licensed vaccine for this virus exists today. The Marburg virus is part of the family of hemorrhagic fever viruses that includes Ebola.
Researchers at the Department of Energy’s Pacific Northwest National Laboratory are helping to lead a transformation of the nation’s century-old electric grid by developing and deploying new technologies to enhance its reliability, resiliency, and security.
The U.S. Food and Drug Administration (FDA) released a revised draft guidance to support compliance with the intentional adulteration (IA) rule set forth under the FDA Food Safety Modernization Act. The IA rule is designed to address hazards that may be intentionally introduced to foods, including by acts of terrorism, with the intent to cause widespread harm to public health.
Emergent BioSolutions Inc. announced that it has signed an indefinite-delivery, indefinite-quantity contract with the U.S. Department of State to establish a long-term, reliable, and stable supply chain for medical countermeasures that address chemical warfare agents. Emergent will be supplying two of its current medical countermeasures addressing chemical threats: the Trobigard® atropine sulfate/obidoxime chloride auto-injector and RSDL® (Reactive Skin Decontamination Lotion Kit).
The Federal Emergency Management Agency (FEMA) and its emergency management partner organizations today posted online Brooke Buddemeier’s PrepTalk “Saving Lives After a Nuclear Detonation.” In his PrepTalk, Buddemeier shares the importance of sheltering after a nuclear detonation and provides emergency managers with tools to help citizens, responders, and city officials get ready.
A new report by a team of researchers at the Johns Hopkins Center for Health Security reframes the discussion of the most severe biological threats to provide policy advocates with an additional tool to help them catalyze expansive international support for work on pandemic prevention and response.